世界のブロムヘキシン市場インサイト及び予測(~2026年)

【英語タイトル】Global Bromhexine Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV03485)・商品コード:QYR20NV03485
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:154
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはブロムヘキシンの世界市場について調査・分析した資料です。種類別(経口、注射)の市場規模、用途別(慢性気管支炎、喘息、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ブロムヘキシンの競争状況、市場シェア
・世界のブロムヘキシン市場:種類別市場規模 2015年-2020年(経口、注射)
・世界のブロムヘキシン市場:種類別市場規模予測 2021年-2026年(経口、注射)
・世界のブロムヘキシン市場:用途別市場規模 2015年-2020年(慢性気管支炎、喘息、その他)
・世界のブロムヘキシン市場:用途別市場規模予測 2021年-2026年(慢性気管支炎、喘息、その他)
・北米のブロムヘキシン市場分析:米国、カナダ
・ヨーロッパのブロムヘキシン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのブロムヘキシン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のブロムヘキシン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのブロムヘキシン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi Aventis、Teva、Boehringer Ingelheim、Novartis、Mylan、Sanyo Chemical Laboratroy、Sandoz、LGM Pharma、GSK、Mayne Pharma、Sigma-Aldrich、Abbott、Shanghai Sine Tianping Pharmaceutical、Takeda、Shanghai Xudong Haipu Pharmaceutical、Jincheng Haisi Pharmaceutical、Shanxi Powerdone Pharmaceutical、Shanxi Powerdone Pharmaceutical、Wanbangde Pharmaceutical Group、Shijiazhuang No.4 Pharmaceutical、Ma'AnShan BBCA Pharmaceutical
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Bromhexine Market
The global Bromhexine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bromhexine Scope and Market Size
Bromhexine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bromhexine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Bromhexine market is segmented into
Oral
Injection

Segment by Application, the Bromhexine market is segmented into
Chronic Bronchitis
Asthma
Other

Regional and Country-level Analysis
The Bromhexine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bromhexine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bromhexine Market Share Analysis
Bromhexine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bromhexine business, the date to enter into the Bromhexine market, Bromhexine product introduction, recent developments, etc.

The major vendors covered:
Sanofi Aventis
Teva
Boehringer Ingelheim
Novartis
Mylan
Sanyo Chemical Laboratroy
Sandoz
LGM Pharma
GSK
Mayne Pharma
Sigma-Aldrich
Abbott
Shanghai Sine Tianping Pharmaceutical
Takeda
Shanghai Xudong Haipu Pharmaceutical
Jincheng Haisi Pharmaceutical
Shanxi Powerdone Pharmaceutical
Shanxi Powerdone Pharmaceutical
Wanbangde Pharmaceutical Group
Shijiazhuang No.4 Pharmaceutical
Ma’AnShan BBCA Pharmaceutical

【レポートの目次】

1 Study Coverage
1.1 Bromhexine Product Introduction
1.2 Market Segments
1.3 Key Bromhexine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bromhexine Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Bromhexine Market Size Growth Rate by Application
1.5.2 Chronic Bronchitis
1.5.3 Asthma
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Bromhexine Market Size, Estimates and Forecasts
2.1.1 Global Bromhexine Revenue 2015-2026
2.1.2 Global Bromhexine Sales 2015-2026
2.2 Global Bromhexine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bromhexine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bromhexine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Bromhexine Competitor Landscape by Players
3.1 Bromhexine Sales by Manufacturers
3.1.1 Bromhexine Sales by Manufacturers (2015-2020)
3.1.2 Bromhexine Sales Market Share by Manufacturers (2015-2020)
3.2 Bromhexine Revenue by Manufacturers
3.2.1 Bromhexine Revenue by Manufacturers (2015-2020)
3.2.2 Bromhexine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bromhexine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bromhexine Revenue in 2019
3.2.5 Global Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bromhexine Price by Manufacturers
3.4 Bromhexine Manufacturing Base Distribution, Product Types
3.4.1 Bromhexine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bromhexine Product Type
3.4.3 Date of International Manufacturers Enter into Bromhexine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bromhexine Market Size by Type (2015-2020)
4.1.1 Global Bromhexine Sales by Type (2015-2020)
4.1.2 Global Bromhexine Revenue by Type (2015-2020)
4.1.3 Bromhexine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bromhexine Market Size Forecast by Type (2021-2026)
4.2.1 Global Bromhexine Sales Forecast by Type (2021-2026)
4.2.2 Global Bromhexine Revenue Forecast by Type (2021-2026)
4.2.3 Bromhexine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bromhexine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Bromhexine Market Size by Application (2015-2020)
5.1.1 Global Bromhexine Sales by Application (2015-2020)
5.1.2 Global Bromhexine Revenue by Application (2015-2020)
5.1.3 Bromhexine Price by Application (2015-2020)
5.2 Bromhexine Market Size Forecast by Application (2021-2026)
5.2.1 Global Bromhexine Sales Forecast by Application (2021-2026)
5.2.2 Global Bromhexine Revenue Forecast by Application (2021-2026)
5.2.3 Global Bromhexine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Bromhexine by Country
6.1.1 North America Bromhexine Sales by Country
6.1.2 North America Bromhexine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bromhexine Market Facts & Figures by Type
6.3 North America Bromhexine Market Facts & Figures by Application

7 Europe
7.1 Europe Bromhexine by Country
7.1.1 Europe Bromhexine Sales by Country
7.1.2 Europe Bromhexine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bromhexine Market Facts & Figures by Type
7.3 Europe Bromhexine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Bromhexine by Region
8.1.1 Asia Pacific Bromhexine Sales by Region
8.1.2 Asia Pacific Bromhexine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bromhexine Market Facts & Figures by Type
8.3 Asia Pacific Bromhexine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Bromhexine by Country
9.1.1 Latin America Bromhexine Sales by Country
9.1.2 Latin America Bromhexine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bromhexine Market Facts & Figures by Type
9.3 Central & South America Bromhexine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Bromhexine by Country
10.1.1 Middle East and Africa Bromhexine Sales by Country
10.1.2 Middle East and Africa Bromhexine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bromhexine Market Facts & Figures by Type
10.3 Middle East and Africa Bromhexine Market Facts & Figures by Application

11 Company Profiles
11.1 Sanofi Aventis
11.1.1 Sanofi Aventis Corporation Information
11.1.2 Sanofi Aventis Description and Business Overview
11.1.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Aventis Bromhexine Products Offered
11.1.5 Sanofi Aventis Related Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description and Business Overview
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Bromhexine Products Offered
11.2.5 Teva Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Bromhexine Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Bromhexine Products Offered
11.4.5 Novartis Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Bromhexine Products Offered
11.5.5 Mylan Related Developments
11.6 Sanyo Chemical Laboratroy
11.6.1 Sanyo Chemical Laboratroy Corporation Information
11.6.2 Sanyo Chemical Laboratroy Description and Business Overview
11.6.3 Sanyo Chemical Laboratroy Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanyo Chemical Laboratroy Bromhexine Products Offered
11.6.5 Sanyo Chemical Laboratroy Related Developments
11.7 Sandoz
11.7.1 Sandoz Corporation Information
11.7.2 Sandoz Description and Business Overview
11.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sandoz Bromhexine Products Offered
11.7.5 Sandoz Related Developments
11.8 LGM Pharma
11.8.1 LGM Pharma Corporation Information
11.8.2 LGM Pharma Description and Business Overview
11.8.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 LGM Pharma Bromhexine Products Offered
11.8.5 LGM Pharma Related Developments
11.9 GSK
11.9.1 GSK Corporation Information
11.9.2 GSK Description and Business Overview
11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GSK Bromhexine Products Offered
11.9.5 GSK Related Developments
11.10 Mayne Pharma
11.10.1 Mayne Pharma Corporation Information
11.10.2 Mayne Pharma Description and Business Overview
11.10.3 Mayne Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mayne Pharma Bromhexine Products Offered
11.10.5 Mayne Pharma Related Developments
11.1 Sanofi Aventis
11.1.1 Sanofi Aventis Corporation Information
11.1.2 Sanofi Aventis Description and Business Overview
11.1.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Aventis Bromhexine Products Offered
11.1.5 Sanofi Aventis Related Developments
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description and Business Overview
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Related Developments
11.13 Shanghai Sine Tianping Pharmaceutical
11.13.1 Shanghai Sine Tianping Pharmaceutical Corporation Information
11.13.2 Shanghai Sine Tianping Pharmaceutical Description and Business Overview
11.13.3 Shanghai Sine Tianping Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Shanghai Sine Tianping Pharmaceutical Products Offered
11.13.5 Shanghai Sine Tianping Pharmaceutical Related Developments
11.14 Takeda
11.14.1 Takeda Corporation Information
11.14.2 Takeda Description and Business Overview
11.14.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Takeda Products Offered
11.14.5 Takeda Related Developments
11.15 Shanghai Xudong Haipu Pharmaceutical
11.15.1 Shanghai Xudong Haipu Pharmaceutical Corporation Information
11.15.2 Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
11.15.3 Shanghai Xudong Haipu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Shanghai Xudong Haipu Pharmaceutical Products Offered
11.15.5 Shanghai Xudong Haipu Pharmaceutical Related Developments
11.16 Jincheng Haisi Pharmaceutical
11.16.1 Jincheng Haisi Pharmaceutical Corporation Information
11.16.2 Jincheng Haisi Pharmaceutical Description and Business Overview
11.16.3 Jincheng Haisi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Jincheng Haisi Pharmaceutical Products Offered
11.16.5 Jincheng Haisi Pharmaceutical Related Developments
11.17 Shanxi Powerdone Pharmaceutical
11.17.1 Shanxi Powerdone Pharmaceutical Corporation Information
11.17.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
11.17.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Shanxi Powerdone Pharmaceutical Products Offered
11.17.5 Shanxi Powerdone Pharmaceutical Related Developments
11.18 Shanxi Powerdone Pharmaceutical
11.18.1 Shanxi Powerdone Pharmaceutical Corporation Information
11.18.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
11.18.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Shanxi Powerdone Pharmaceutical Products Offered
11.18.5 Shanxi Powerdone Pharmaceutical Related Developments
11.19 Wanbangde Pharmaceutical Group
11.19.1 Wanbangde Pharmaceutical Group Corporation Information
11.19.2 Wanbangde Pharmaceutical Group Description and Business Overview
11.19.3 Wanbangde Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Wanbangde Pharmaceutical Group Products Offered
11.19.5 Wanbangde Pharmaceutical Group Related Developments
11.20 Shijiazhuang No.4 Pharmaceutical
11.20.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
11.20.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
11.20.3 Shijiazhuang No.4 Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Shijiazhuang No.4 Pharmaceutical Products Offered
11.20.5 Shijiazhuang No.4 Pharmaceutical Related Developments
11.21 Ma’AnShan BBCA Pharmaceutical
11.21.1 Ma’AnShan BBCA Pharmaceutical Corporation Information
11.21.2 Ma’AnShan BBCA Pharmaceutical Description and Business Overview
11.21.3 Ma’AnShan BBCA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Ma’AnShan BBCA Pharmaceutical Products Offered
11.21.5 Ma’AnShan BBCA Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bromhexine Market Estimates and Projections by Region
12.1.1 Global Bromhexine Sales Forecast by Regions 2021-2026
12.1.2 Global Bromhexine Revenue Forecast by Regions 2021-2026
12.2 North America Bromhexine Market Size Forecast (2021-2026)
12.2.1 North America: Bromhexine Sales Forecast (2021-2026)
12.2.2 North America: Bromhexine Revenue Forecast (2021-2026)
12.2.3 North America: Bromhexine Market Size Forecast by Country (2021-2026)
12.3 Europe Bromhexine Market Size Forecast (2021-2026)
12.3.1 Europe: Bromhexine Sales Forecast (2021-2026)
12.3.2 Europe: Bromhexine Revenue Forecast (2021-2026)
12.3.3 Europe: Bromhexine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bromhexine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bromhexine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bromhexine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bromhexine Market Size Forecast by Region (2021-2026)
12.5 Latin America Bromhexine Market Size Forecast (2021-2026)
12.5.1 Latin America: Bromhexine Sales Forecast (2021-2026)
12.5.2 Latin America: Bromhexine Revenue Forecast (2021-2026)
12.5.3 Latin America: Bromhexine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bromhexine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bromhexine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bromhexine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bromhexine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bromhexine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bromhexine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Bromhexine Market Segments
Table 2. Ranking of Global Top Bromhexine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bromhexine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Bromhexine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Bromhexine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Bromhexine Sales by Regions 2015-2020 (K MT)
Table 9. Global Bromhexine Sales Market Share by Regions (2015-2020)
Table 10. Global Bromhexine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Bromhexine Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Bromhexine Sales Share by Manufacturers (2015-2020)
Table 13. Global Bromhexine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Bromhexine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bromhexine as of 2019)
Table 15. Bromhexine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Bromhexine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Bromhexine Price (2015-2020) (USD/MT)
Table 18. Bromhexine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Bromhexine Product Type
Table 20. Date of International Manufacturers Enter into Bromhexine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Bromhexine Sales by Type (2015-2020) (K MT)
Table 23. Global Bromhexine Sales Share by Type (2015-2020)
Table 24. Global Bromhexine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Bromhexine Revenue Share by Type (2015-2020)
Table 26. Bromhexine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Bromhexine Sales by Application (2015-2020) (K MT)
Table 28. Global Bromhexine Sales Share by Application (2015-2020)
Table 29. North America Bromhexine Sales by Country (2015-2020) (K MT)
Table 30. North America Bromhexine Sales Market Share by Country (2015-2020)
Table 31. North America Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Bromhexine Revenue Market Share by Country (2015-2020)
Table 33. North America Bromhexine Sales by Type (2015-2020) (K MT)
Table 34. North America Bromhexine Sales Market Share by Type (2015-2020)
Table 35. North America Bromhexine Sales by Application (2015-2020) (K MT)
Table 36. North America Bromhexine Sales Market Share by Application (2015-2020)
Table 37. Europe Bromhexine Sales by Country (2015-2020) (K MT)
Table 38. Europe Bromhexine Sales Market Share by Country (2015-2020)
Table 39. Europe Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Bromhexine Revenue Market Share by Country (2015-2020)
Table 41. Europe Bromhexine Sales by Type (2015-2020) (K MT)
Table 42. Europe Bromhexine Sales Market Share by Type (2015-2020)
Table 43. Europe Bromhexine Sales by Application (2015-2020) (K MT)
Table 44. Europe Bromhexine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Bromhexine Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Bromhexine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Bromhexine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Bromhexine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Bromhexine Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Bromhexine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Bromhexine Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Bromhexine Sales Market Share by Application (2015-2020)
Table 53. Latin America Bromhexine Sales by Country (2015-2020) (K MT)
Table 54. Latin America Bromhexine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Bromhexine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Bromhexine Sales by Type (2015-2020) (K MT)
Table 58. Latin America Bromhexine Sales Market Share by Type (2015-2020)
Table 59. Latin America Bromhexine Sales by Application (2015-2020) (K MT)
Table 60. Latin America Bromhexine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Bromhexine Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Bromhexine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Bromhexine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bromhexine Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Bromhexine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Bromhexine Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Bromhexine Sales Market Share by Application (2015-2020)
Table 69. Sanofi Aventis Corporation Information
Table 70. Sanofi Aventis Description and Major Businesses
Table 71. Sanofi Aventis Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Sanofi Aventis Product
Table 73. Sanofi Aventis Recent Development
Table 74. Teva Corporation Information
Table 75. Teva Description and Major Businesses
Table 76. Teva Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Product
Table 78. Teva Recent Development
Table 79. Boehringer Ingelheim Corporation Information
Table 80. Boehringer Ingelheim Description and Major Businesses
Table 81. Boehringer Ingelheim Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Boehringer Ingelheim Product
Table 83. Boehringer Ingelheim Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Mylan Corporation Information
Table 90. Mylan Description and Major Businesses
Table 91. Mylan Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mylan Product
Table 93. Mylan Recent Development
Table 94. Sanyo Chemical Laboratroy Corporation Information
Table 95. Sanyo Chemical Laboratroy Description and Major Businesses
Table 96. Sanyo Chemical Laboratroy Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Sanyo Chemical Laboratroy Product
Table 98. Sanyo Chemical Laboratroy Recent Development
Table 99. Sandoz Corporation Information
Table 100. Sandoz Description and Major Businesses
Table 101. Sandoz Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Sandoz Product
Table 103. Sandoz Recent Development
Table 104. LGM Pharma Corporation Information
Table 105. LGM Pharma Description and Major Businesses
Table 106. LGM Pharma Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. LGM Pharma Product
Table 108. LGM Pharma Recent Development
Table 109. GSK Corporation Information
Table 110. GSK Description and Major Businesses
Table 111. GSK Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GSK Product
Table 113. GSK Recent Development
Table 114. Mayne Pharma Corporation Information
Table 115. Mayne Pharma Description and Major Businesses
Table 116. Mayne Pharma Bromhexine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Mayne Pharma Product
Table 118. Mayne Pharma Recent Development
Table 119. Sigma-Aldrich Corporation Information
Table 120. Sigma-Aldrich Description and Major Businesses
Table 121. Sigma-Aldrich Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sigma-Aldrich Product
Table 123. Sigma-Aldrich Recent Development
Table 124. Abbott Corporation Information
Table 125. Abbott Description and Major Businesses
Table 126. Abbott Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Abbott Product
Table 128. Abbott Recent Development
Table 129. Shanghai Sine Tianping Pharmaceutical Corporation Information
Table 130. Shanghai Sine Tianping Pharmaceutical Description and Major Businesses
Table 131. Shanghai Sine Tianping Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Shanghai Sine Tianping Pharmaceutical Product
Table 133. Shanghai Sine Tianping Pharmaceutical Recent Development
Table 134. Takeda Corporation Information
Table 135. Takeda Description and Major Businesses
Table 136. Takeda Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Takeda Product
Table 138. Takeda Recent Development
Table 139. Shanghai Xudong Haipu Pharmaceutical Corporation Information
Table 140. Shanghai Xudong Haipu Pharmaceutical Description and Major Businesses
Table 141. Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Shanghai Xudong Haipu Pharmaceutical Product
Table 143. Shanghai Xudong Haipu Pharmaceutical Recent Development
Table 144. Jincheng Haisi Pharmaceutical Corporation Information
Table 145. Jincheng Haisi Pharmaceutical Description and Major Businesses
Table 146. Jincheng Haisi Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Jincheng Haisi Pharmaceutical Product
Table 148. Jincheng Haisi Pharmaceutical Recent Development
Table 149. Shanxi Powerdone Pharmaceutical Corporation Information
Table 150. Shanxi Powerdone Pharmaceutical Description and Major Businesses
Table 151. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Shanxi Powerdone Pharmaceutical Product
Table 153. Shanxi Powerdone Pharmaceutical Recent Development
Table 154. Shanxi Powerdone Pharmaceutical Corporation Information
Table 155. Shanxi Powerdone Pharmaceutical Description and Major Businesses
Table 156. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Shanxi Powerdone Pharmaceutical Product
Table 158. Shanxi Powerdone Pharmaceutical Recent Development
Table 159. Wanbangde Pharmaceutical Group Corporation Information
Table 160. Wanbangde Pharmaceutical Group Description and Major Businesses
Table 161. Wanbangde Pharmaceutical Group Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Wanbangde Pharmaceutical Group Product
Table 163. Wanbangde Pharmaceutical Group Recent Development
Table 164. Shijiazhuang No.4 Pharmaceutical Corporation Information
Table 165. Shijiazhuang No.4 Pharmaceutical Description and Major Businesses
Table 166. Shijiazhuang No.4 Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Shijiazhuang No.4 Pharmaceutical Product
Table 168. Shijiazhuang No.4 Pharmaceutical Recent Development
Table 169. Ma'AnShan BBCA Pharmaceutical Corporation Information
Table 170. Ma'AnShan BBCA Pharmaceutical Description and Major Businesses
Table 171. Ma'AnShan BBCA Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Ma'AnShan BBCA Pharmaceutical Product
Table 173. Ma'AnShan BBCA Pharmaceutical Recent Development
Table 174. Global Bromhexine Sales Forecast by Regions (2021-2026) (K MT)
Table 175. Global Bromhexine Sales Market Share Forecast by Regions (2021-2026)
Table 176. Global Bromhexine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 177. Global Bromhexine Revenue Market Share Forecast by Regions (2021-2026)
Table 178. North America: Bromhexine Sales Forecast by Country (2021-2026) (K MT)
Table 179. North America: Bromhexine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 180. Europe: Bromhexine Sales Forecast by Country (2021-2026) (K MT)
Table 181. Europe: Bromhexine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 182. Asia Pacific: Bromhexine Sales Forecast by Region (2021-2026) (K MT)
Table 183. Asia Pacific: Bromhexine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 184. Latin America: Bromhexine Sales Forecast by Country (2021-2026) (K MT)
Table 185. Latin America: Bromhexine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Middle East and Africa: Bromhexine Sales Forecast by Country (2021-2026) (K MT)
Table 187. Middle East and Africa: Bromhexine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 189. Key Challenges
Table 190. Market Risks
Table 191. Main Points Interviewed from Key Bromhexine Players
Table 192. Bromhexine Customers List
Table 193. Bromhexine Distributors List
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Bromhexine Product Picture
Figure 2. Global Bromhexine Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Bromhexine Sales Market Share by Application in 2020 & 2026
Figure 6. Chronic Bronchitis
Figure 7. Asthma
Figure 8. Other
Figure 9. Bromhexine Report Years Considered
Figure 10. Global Bromhexine Market Size 2015-2026 (US$ Million)
Figure 11. Global Bromhexine Sales 2015-2026 (K MT)
Figure 12. Global Bromhexine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Bromhexine Sales Market Share by Region (2015-2020)
Figure 14. Global Bromhexine Sales Market Share by Region in 2019
Figure 15. Global Bromhexine Revenue Market Share by Region (2015-2020)
Figure 16. Global Bromhexine Revenue Market Share by Region in 2019
Figure 17. Global Bromhexine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Bromhexine Revenue in 2019
Figure 19. Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Bromhexine Sales Market Share by Type (2015-2020)
Figure 21. Global Bromhexine Sales Market Share by Type in 2019
Figure 22. Global Bromhexine Revenue Market Share by Type (2015-2020)
Figure 23. Global Bromhexine Revenue Market Share by Type in 2019
Figure 24. Global Bromhexine Market Share by Price Range (2015-2020)
Figure 25. Global Bromhexine Sales Market Share by Application (2015-2020)
Figure 26. Global Bromhexine Sales Market Share by Application in 2019
Figure 27. Global Bromhexine Revenue Market Share by Application (2015-2020)
Figure 28. Global Bromhexine Revenue Market Share by Application in 2019
Figure 29. North America Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Bromhexine Sales Market Share by Country in 2019
Figure 32. North America Bromhexine Revenue Market Share by Country in 2019
Figure 33. U.S. Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Bromhexine Market Share by Type in 2019
Figure 38. North America Bromhexine Market Share by Application in 2019
Figure 39. Europe Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Bromhexine Sales Market Share by Country in 2019
Figure 42. Europe Bromhexine Revenue Market Share by Country in 2019
Figure 43. Germany Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Bromhexine Market Share by Type in 2019
Figure 54. Europe Bromhexine Market Share by Application in 2019
Figure 55. Asia Pacific Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Bromhexine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Bromhexine Revenue Market Share by Region in 2019
Figure 59. China Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Bromhexine Market Share by Type in 2019
Figure 82. Asia Pacific Bromhexine Market Share by Application in 2019
Figure 83. Latin America Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Bromhexine Sales Market Share by Country in 2019
Figure 86. Latin America Bromhexine Revenue Market Share by Country in 2019
Figure 87. Mexico Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Bromhexine Market Share by Type in 2019
Figure 94. Latin America Bromhexine Market Share by Application in 2019
Figure 95. Middle East and Africa Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Bromhexine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Bromhexine Revenue Market Share by Country in 2019
Figure 99. Turkey Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Bromhexine Market Share by Type in 2019
Figure 106. Middle East and Africa Bromhexine Market Share by Application in 2019
Figure 107. North America Bromhexine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Bromhexine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Bromhexine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Bromhexine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Bromhexine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Bromhexine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Bromhexine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Bromhexine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Bromhexine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Bromhexine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed


【掲載企業】

Sanofi Aventis、Teva、Boehringer Ingelheim、Novartis、Mylan、Sanyo Chemical Laboratroy、Sandoz、LGM Pharma、GSK、Mayne Pharma、Sigma-Aldrich、Abbott、Shanghai Sine Tianping Pharmaceutical、Takeda、Shanghai Xudong Haipu Pharmaceutical、Jincheng Haisi Pharmaceutical、Shanxi Powerdone Pharmaceutical、Shanxi Powerdone Pharmaceutical、Wanbangde Pharmaceutical Group、Shijiazhuang No.4 Pharmaceutical、Ma'AnShan BBCA Pharmaceutical

★調査レポート[世界のブロムヘキシン市場インサイト及び予測(~2026年)] (コード:QYR20NV03485)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のブロムヘキシン市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆